This study is dedicated to delve into the impact of the relationship between temozolomide and the LINC00470/EGR2/SOX4 axis on glioblastoma progression, thus presenting a fresh theoretical basis for the treatment of glioblastoma with temozolomide. Here, LINC00470 is linked to glioblastoma.